Suppr超能文献

FOUR评分,一种用于评估肝硬化患者显性肝性脑病的可靠评分。

FOUR score, a reliable score for assessing overt hepatic encephalopathy in cirrhotic patients.

作者信息

Mouri Sarah, Tripon Simona, Rudler Marika, Mallet Maxime, Mayaux Julien, Thabut Dominique, Weiss Nicolas

机构信息

Brain-Liver Pitié-Salpêtrière Study Group (BLIPS), Paris, France.

出版信息

Neurocrit Care. 2015 Apr;22(2):251-7. doi: 10.1007/s12028-014-0078-5.

Abstract

BACKGROUND

Hepatic encephalopathy (HE) is a frequent complication of cirrhosis and a major public health problem. The incidence is increasing because of improved cirrhosis prognosis. The most widely used scale used to evaluate HE is the West-Haven (WH) scale, with scores ranging from 0 to 4. This scale is easy to use but not suitable for patients with altered consciousness and is not well known by physicians other than hepatologists who manage these conditions. For deep coma, the validated Glasgow Coma Scale (GCS) has been proposed. A new scale for comatose patients, the Full Outline of UnResponsiveness (FOUR) score, has recently been proposed and widely validated. The scale covers eye and motor responses, brainstem reflexes and breathing patterns and is the most validated coma scale.

OBJECTIVE

To assess the diagnostic value of the FOUR score for detecting overt HE (OHE) in cirrhotic patients.

METHODS

We prospectively included all patients admitted for cirrhosis at La Pitié-Salpêtrière Hospital from June 2012 to March 2014. Neurological status was assessed by a senior neurologic intensive care physician in the 24 first hours of ICU admission. The recently described and validated French version of the FOUR score was used.

RESULTS

We screened 100 cirrhotic patients and included 94 (70 males [75 %], mean age 57 ± 11 years): 29 (31 %) with OHE (WH grades 2-4) and 65 (69 %) with No-OHE (WH grades 0-1). Mean FOUR and GCS scores were lower for OHE than No-OHE patients (p < 0.0001). The FOUR score could distinguish between WH grades 0-1, 2-3 and 4 (p < 0.0001). Furthermore, it could accurately detect and quantify OHE with an area under the c-index of 0.88 ± 0.10. The FOUR score was associated with outcome.

CONCLUSION

The FOUR score can be used to detect and quantify HE in cirrhotic patients, especially by non-hepatologists who are not familiar with the WH scale.

摘要

背景

肝性脑病(HE)是肝硬化常见的并发症,也是一个主要的公共卫生问题。由于肝硬化预后改善,其发病率正在上升。用于评估HE最广泛使用的量表是韦斯特-黑文(WH)量表,评分范围为0至4分。该量表易于使用,但不适用于意识改变的患者,除管理这些疾病的肝病学家外,其他医生对其并不熟悉。对于深度昏迷,已有人提出使用经过验证的格拉斯哥昏迷量表(GCS)。最近有人提出了一种针对昏迷患者的新量表——全面无反应性大纲(FOUR)评分,并已得到广泛验证。该量表涵盖了眼部和运动反应、脑干反射及呼吸模式,是经过最多验证的昏迷量表。

目的

评估FOUR评分对检测肝硬化患者显性肝性脑病(OHE)的诊断价值。

方法

我们前瞻性纳入了2012年6月至2014年3月在拉皮蒂-萨尔佩特里埃医院因肝硬化入院的所有患者。在入住重症监护病房的头24小时内,由一位资深神经重症监护医师对患者的神经状态进行评估。采用最近描述并经验证的法语版FOUR评分。

结果

我们筛查了100例肝硬化患者,纳入94例(70例男性[75%],平均年龄57±11岁):29例(31%)患有OHE(WH分级2 - 4级),65例(69%)未患OHE(WH分级0 - 1级)。OHE患者的平均FOUR和GCS评分低于未患OHE的患者(p < 0.0001)。FOUR评分能够区分WH分级0 - 1级、2 - 3级和4级(p < 0.0001)。此外,它能够准确检测和量化OHE,c指数下的面积为0.88±0.10。FOUR评分与预后相关。

结论

FOUR评分可用于检测和量化肝硬化患者的肝性脑病,尤其是对于不熟悉WH量表 的非肝病学家而言。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验